Clinical Trials

Showing trials with last updates posted in 2023.

NCT04187872 | TERMINATED | PHASE1
10 participants

LITT and Pembrolizumab in Recurrent Brain Metastasis

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-27
Start Date:
2020-01-10
Completion:
2023-12-01
Conditions
  • Melanoma
  • Non-small Cell Lung Carcinoma (NSCLC)
  • Renal Cell Carcinoma (RCC)
  • Small-cell Lung Cancer
  • Head and Neck Squamous Cell Cancer
  • Classical Hodgkin Lymphoma
  • Primary Mediastinal Large B-Cell Lymphoma
  • Urothelial Carcinoma
  • Microsatellite Instability-High Cancer
  • Gastric Cancer
  • Esophageal Cancer
  • Cervical Cancer
  • Hepatocellular Carcinoma
  • Merkel Cell Carcinoma
  • Brain Metastases, Adult
Interventions
  • COMBINATION_PRODUCT
No Results Yet
NCT04136457 | COMPLETED | NA
72 participants

Proteome Remodelling

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-27
Start Date:
2019-10-30
Completion:
2023-11-28
Conditions
  • Skeletal Muscle Physiology
Interventions
  • OTHER
No Results Yet
NCT04068207 | COMPLETED | PHASE2
35 participants

Minocycline Treatment in Retinitis Pigmentosa

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-27
Start Date:
2019-08-25
Completion:
2023-01-31
Conditions
  • Retinitis Pigmentosa
  • Inherited Retinal Dystrophy
  • Retina Disorder
Interventions
  • DRUG
No Results Yet
NCT03991000 | TERMINATED | PHASE3
8 participants

Iron in Patients With Cardiovascular Disease

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-27
Start Date:
2019-02-28
Completion:
2021-12-15
Conditions
  • Cardiovascular Diseases
  • Anemia, Iron-deficiency
  • Acute Myocardial Infarction
  • Atrial Fibrillation
  • Systolic Heart Failure
Interventions
  • DRUG
No Results Yet
NCT02365649 | COMPLETED | PHASE2
220 participants
Previous
Sorted by latest updates
Next
Showing 40 trials per page